89 related articles for article (PubMed ID: 3814105)
1. Central effects of leukotriene C4 and D4 in rats and mice.
Brus R; Krzeminski T; Juraszczyk Z; Kurcok A; Felinska W; Kozik W
Biomed Biochim Acta; 1986; 45(9):1153-8. PubMed ID: 3814105
[TBL] [Abstract][Full Text] [Related]
2. Central action of 6-hydroxytryptamine in rats.
Jamrozik-Kruk Z; Brus R
Acta Physiol Pol; 1980; 31(3):253-60. PubMed ID: 6160727
[TBL] [Abstract][Full Text] [Related]
3. Central action of melanostatin (MIF-1) in mice.
Brus R; Szkilnik R; Stanosek B; Makowska B; Piguła J
Acta Physiol Pol; 1984; 35(5-6):447-53. PubMed ID: 6152791
[TBL] [Abstract][Full Text] [Related]
4. Studies on the behavioral and hypotensive effects of intraventricular prostacyclin (PGI2) in rats.
Brus K; Szkilnik R; Słomińska-Zurek J; Krzemiński T; Herman ZS
Pol J Pharmacol Pharm; 1981 Nov; 33(4):467-74. PubMed ID: 7036117
[TBL] [Abstract][Full Text] [Related]
5. Central action of low-molecular weight polyphloretin phosphate fraction in rats.
Zabawska J
Acta Physiol Pol; 1980; 31(5):493-500. PubMed ID: 6785998
[TBL] [Abstract][Full Text] [Related]
6. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
7. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
8. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
[TBL] [Abstract][Full Text] [Related]
9. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
10. Effect of oleamide on sleep and its relationship to blood pressure, body temperature, and locomotor activity in rats.
Huitrón-Reséndiz S; Gombart L; Cravatt BF; Henriksen SJ
Exp Neurol; 2001 Nov; 172(1):235-43. PubMed ID: 11681856
[TBL] [Abstract][Full Text] [Related]
11. Central action of drugs acting on the cholinergic muscarinic receptor. II. Influence of ecothiopate administered into the lateral cerebral ventricle on behavior in rats.
Kleinrok Z; Wielosz M; Przegaliński E
Arch Immunol Ther Exp (Warsz); 1975; 23(4):477-84. PubMed ID: 1172420
[TBL] [Abstract][Full Text] [Related]
12. Role of H2 receptors in the central and peripheral effects of prostacyclin [PGI2] on circulatory system in rats.
Krzeminski T; Brus R; Juraszczyk Z; Kurcok A; Pogorzelska T
Biomed Biochim Acta; 1984; 43(8-9):S199-202. PubMed ID: 6393966
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular responses to leukotriene C4 in the rat.
Iacopino VJ; Fitzpatrick TM; Ramwell PW; Rose JC; Kot PA
J Pharmacol Exp Ther; 1983 Oct; 227(1):244-7. PubMed ID: 6620169
[TBL] [Abstract][Full Text] [Related]
14. Central action of PGE1 on the cerebral neurotransmission; the cardiovascular response.
Krzemiński T; Kurcok A; Brus R
Biomed Biochim Acta; 1988; 47(10-11):S328-32. PubMed ID: 2854731
[TBL] [Abstract][Full Text] [Related]
15. The central action of 5-allyl-5-(beta-hydroxypropyl)-N-phenylbarbituric acid and the corresponding lactone.
Sieroslawska J; Czarnecki R; Sypniewska M; Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1973; 25(2):113-26. PubMed ID: 4798099
[No Abstract] [Full Text] [Related]
16. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
[No Abstract] [Full Text] [Related]
17. Central action of adrenaline.
Jagiełło-Wójtowicz E
Acta Physiol Pol; 1981; 32(2):169-80. PubMed ID: 7196677
[TBL] [Abstract][Full Text] [Related]
18. The influence of central chemical sympathectomy and reserpine on peripheral effects of noradrenaline and cyclic AMP dibutyrate injected into the cerebral ventricles.
Brus R; Herman ZS; Dzikowski A; Zabawska J
Arch Immunol Ther Exp (Warsz); 1976; 24(4):537-42. PubMed ID: 187139
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomography.
Vaupel DB; Tella SR; Huso DL; Wagner VO; Mukhin AG; Chefer SI; Horti AG; London ED; Koren AO; Kimes AS
J Pharmacol Exp Ther; 2005 Jan; 312(1):355-65. PubMed ID: 15331657
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular and respiratory effects of beta-endorphin in anesthetized and conscious rats.
Sitsen JM; Van Ree JM; De Jong W
J Cardiovasc Pharmacol; 1982; 4(6):883-8. PubMed ID: 6185778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
